Core Viewpoint - The company is focusing on biodegradable materials as a key strategic development direction, with plans to increase capital for its subsidiary to enhance its financial structure [1] Group 1: Company Strategy - The company announced a capital increase of 150 million yuan to its subsidiary, Jiangxi Academy of Biological New Materials Co., Ltd. [1] - The subsidiary primarily engages in the research, production, and sales of lactic acid and polylactic acid [1] - Other shareholders of the subsidiary will not participate in this capital increase [1]

Core Viewpoint - The company is focusing on biodegradable materials as a key strategic development direction, with plans to enhance its subsidiary's financial structure through a capital increase [1] Group 1: Company Strategy - The company plans to invest 150 million yuan in its subsidiary, Jiangxi Academy of Biological New Materials Co., Ltd., to accelerate strategic layout and development [1] - The capital increase aims to supplement the working capital of the subsidiary and improve its asset-liability structure [1] Group 2: Subsidiary Operations - Jiangxi Academy of Biological New Materials Co., Ltd. is primarily engaged in the research, production, and sales of lactic acid and polylactic acid [1] - Other shareholders of the subsidiary will not participate in this capital increase [1]

Core Viewpoint - The company is focusing on biodegradable materials as a key strategic development direction, with plans to increase capital for its subsidiary to enhance its financial structure and support growth [1] Group 1: Company Strategy - The company intends to invest 150 million yuan in its subsidiary, Jiangxi Academy of Biological New Materials Co., Ltd. (referred to as "Academy Biology"), to accelerate its strategic layout and development [1] - The investment aims to supplement the working capital of Academy Biology and improve its asset-liability structure [1] Group 2: Subsidiary Operations - Academy Biology primarily engages in the research, production, and sales of lactic acid and polylactic acid [1] - The other shareholders of Academy Biology will not participate in this capital increase [1]